Radnor Capital Management LLC Purchases 299 Shares of Cardinal Health, Inc. (NYSE:CAH)

Radnor Capital Management LLC raised its position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 14.2% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,409 shares of the company’s stock after purchasing an additional 299 shares during the period. Radnor Capital Management LLC’s holdings in Cardinal Health were worth $266,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp raised its position in Cardinal Health by 101.1% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 321,558 shares of the company’s stock valued at $36,010,000 after purchasing an additional 161,656 shares in the last quarter. State Board of Administration of Florida Retirement System increased its holdings in shares of Cardinal Health by 5.2% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 314,213 shares of the company’s stock valued at $35,160,000 after acquiring an additional 15,663 shares during the period. Alpha Cubed Investments LLC purchased a new position in shares of Cardinal Health in the 3rd quarter valued at $371,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in shares of Cardinal Health by 1.7% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 393,350 shares of the company’s stock valued at $44,016,000 after acquiring an additional 6,752 shares during the period. Finally, Bessemer Group Inc. increased its holdings in shares of Cardinal Health by 38.7% in the 1st quarter. Bessemer Group Inc. now owns 19,190 shares of the company’s stock valued at $2,148,000 after acquiring an additional 5,352 shares during the period. 87.17% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Morgan Stanley lifted their price target on Cardinal Health from $119.00 to $127.00 and gave the company an “overweight” rating in a report on Monday. Deutsche Bank Aktiengesellschaft lifted their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday. Evercore ISI lifted their price target on Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a report on Thursday, August 15th. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Finally, Mizuho boosted their target price on Cardinal Health from $110.00 to $120.00 and gave the stock a “neutral” rating in a research note on Monday. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $123.00.

Read Our Latest Analysis on Cardinal Health

Insider Activity

In other news, CEO Jason M. Hollar sold 26,716 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $108.87, for a total value of $2,908,570.92. Following the completion of the transaction, the chief executive officer now owns 244,091 shares of the company’s stock, valued at $26,574,187.17. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CFO Aaron E. Alt sold 2,323 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.91, for a total value of $252,997.93. Following the completion of the transaction, the chief financial officer now owns 36,867 shares of the company’s stock, valued at approximately $4,015,184.97. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jason M. Hollar sold 26,716 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $108.87, for a total value of $2,908,570.92. Following the completion of the transaction, the chief executive officer now directly owns 244,091 shares of the company’s stock, valued at $26,574,187.17. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 113,963 shares of company stock valued at $12,379,980 in the last quarter. 0.09% of the stock is currently owned by company insiders.

Cardinal Health Stock Performance

Cardinal Health stock opened at $118.22 on Friday. The business’s 50-day simple moving average is $112.07 and its two-hundred day simple moving average is $104.41. The company has a market cap of $28.61 billion, a PE ratio of 23.00, a PEG ratio of 1.39 and a beta of 0.60. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $119.58.

Cardinal Health (NYSE:CAHGet Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The business had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.73 EPS. As a group, analysts predict that Cardinal Health, Inc. will post 7.84 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.71%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.